BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 17308084)

  • 1. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2).
    Nagel S; Kaufmann M; Drexler HG; MacLeod RA
    Cancer Res; 2003 Sep; 63(17):5329-34. PubMed ID: 14500364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
    Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
    Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).
    Su XY; Della-Valle V; Andre-Schmutz I; Lemercier C; Radford-Weiss I; Ballerini P; Lessard M; Lafage-Pochitaloff M; Mugneret F; Berger R; Romana SP; Bernard OA; Penard-Lacronique V
    Blood; 2006 Dec; 108(13):4198-201. PubMed ID: 16926283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).
    MacLeod RA; Nagel S; Kaufmann M; Janssen JW; Drexler HG
    Genes Chromosomes Cancer; 2003 May; 37(1):84-91. PubMed ID: 12661009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a novel recombination between the homeobox gene NKX2-5 and the TRD locus in T-cell acute lymphoblastic leukemia on activation of the NKX2-5 gene.
    Przybylski GK; Dik WA; Grabarczyk P; Wanzeck J; Chudobska P; Jankowski K; von Bergh A; van Dongen JJ; Schmidt CA; Langerak AW
    Haematologica; 2006 Mar; 91(3):317-21. PubMed ID: 16531254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia.
    van Zutven LJ; Velthuizen SC; Wolvers-Tettero IL; van Dongen JJ; Poulsen TS; MacLeod RA; Beverloo HB; Langerak AW
    Haematologica; 2004 Jun; 89(6):671-8. PubMed ID: 15194534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.
    Bernard OA; Busson-LeConiat M; Ballerini P; Mauchauffé M; Della Valle V; Monni R; Nguyen Khac F; Mercher T; Penard-Lacronique V; Pasturaud P; Gressin L; Heilig R; Daniel MT; Lessard M; Berger R
    Leukemia; 2001 Oct; 15(10):1495-504. PubMed ID: 11587205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia.
    Su XY; Busson M; Della Valle V; Ballerini P; Dastugue N; Talmant P; Ferrando AA; Baudry-Bluteau D; Romana S; Berger R; Bernard OA
    Genes Chromosomes Cancer; 2004 Nov; 41(3):243-9. PubMed ID: 15334547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
    Ehrlich LA; Yang-Iott K; Bassing CH
    Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3.
    Su X; Drabkin H; Clappier E; Morgado E; Busson M; Romana S; Soulier J; Berger R; Bernard OA; Lavau C
    Genes Chromosomes Cancer; 2006 Sep; 45(9):846-55. PubMed ID: 16804919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the RanBP17/Hox11L2 region by recombination with the TCRdelta locus in acute lymphoblastic leukemias with t(5;14)(q34;q11).
    Hansen-Hagge TE; Schäfer M; Kiyoi H; Morris SW; Whitlock JA; Koch P; Bohlmann I; Mahotka C; Bartram CR; Janssen JW
    Leukemia; 2002 Nov; 16(11):2205-12. PubMed ID: 12399963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional activation of the cardiac homeobox gene CSX1/NKX2-5 in a B-cell chronic lymphoproliferative disorder.
    Su X; Della-Valle V; Delabesse E; Azgui Z; Berger R; Merle-Béral H; Bernard OA; Nguyen-Khac F
    Haematologica; 2008 Jul; 93(7):1081-5. PubMed ID: 18492690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
    Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
    Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKX2-5, SIL/TAL and TLX3/HOX11L2 expression in Egyptian pediatric T-cell acute lymphoblastic leukemia.
    Moussa H; Sidhom I
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e1-10. PubMed ID: 24571118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.
    Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
    Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
    Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
    Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient.
    Fujimoto R; Ozawa T; Itoyama T; Sadamori N; Kurosawa N; Isobe M
    Cancer Genet; 2012; 205(7-8):356-64. PubMed ID: 22867996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.
    Przybylski GK; Dik WA; Wanzeck J; Grabarczyk P; Majunke S; Martin-Subero JI; Siebert R; Dölken G; Ludwig WD; Verhaaf B; van Dongen JJ; Schmidt CA; Langerak AW
    Leukemia; 2005 Feb; 19(2):201-8. PubMed ID: 15668700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
    Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
    Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.